Business Name: |
Genestitute |
Contact Person: |
Lillian Zheng |
Address: |
8860 Kenamar Drive # 308, San Diego, California 92121 |
Phone Number: |
(858) 547-9680 |
Annual Revenue (USD): |
$50.000 to $99.999 |
Founding Year: |
2002 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2B (Business to Business) |
Business Category: |
Commercial Biotechnical Research |
SIC Code: |
8731 |
NAICS Code: |
541711 |
Share This Business: |
|
Related Businesses: |
Proacta Inc - San Diego, CA 92121 Abide Therapeutics - San Diego, CA 92121 Miltenyi Biotec Inc - San Diego, CA 92121 Ignyta - San Diego, CA 92121 Center For Aquaculture Tech - San Diego, CA 92121 Aires Pharmaceuticals Inc - San Diego, CA 92121 Oranox - San Diego, CA 92121 Rd Biosciences Inc - San Diego, CA 92121 Zenobia Therapeutics - San Diego, CA 92121 Arytha Biosciences LLC - San Diego, CA 92121 Abwiz Bio Inc - San Diego, CA 92121 Advantar Laboratories Inc - San Diego, CA 92121 Anaptysbio Inc - San Diego, CA 92121 Nod Pharmaceuticals Inc - San Diego, CA 92121 Kinome Scan - San Diego, CA 92121 Dermatrends Inc - San Diego, CA 92121 One World Lab Inc - San Diego, CA 92121 Motivatrx LLC - San Diego, CA 92121 Mapp Biopharmaceutical Inc - San Diego, CA 92121 Fate Therapeutics Inc - San Diego, CA 92121 |
The company Genestitute provides B2B services in the form of Commercial Biotechnical Research from its single location in California.
1 to 4 employees work for Genestitute, and the business now earns $50.000 to $99.999 per annum.
Genestitute was launched in 2002 and is classified under SIC code and category 8731 , and NAICS number and grouping 541711 .
To contact Genestitute, please call Lillian Zheng with the phone number (858) 547-9680 or visit its single location at 8860 Kenamar Drive # 308 in San Diego, California 92121.
The location of the single location can also be found using the coordinates 32.885043,-117.155902.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.